Subscribe
Sign In
Continue to Site
»
Site will load in
15
seconds
Continue to Site »
X
Federal Cannabis Legalization: Page 3
Behind DEA’s 1975 Admission That Rescheduling Cannabis Does Not Violate International Treaty
The DEA’s refusal to reschedule cannabis nearly 50 years ago derived from HHS predecessor’s failure to recognize its medical value, not a 1961 treaty.
US Senator Says ‘Congress Has Failed’ to Keep Up on Cannabis Reform
Sen. Jacky Rosen said Nevada’s economy and small businesses have benefited from legalization.
DEA, Attorney General Miss Deadline to Respond to 12 US Senators on Cannabis Rescheduling
The Drug Enforcement Administration continues to keep its process behind closed doors despite a congressional letter demanding transparency.
VP Kamala Harris Touts Changing ‘Federal Marijuana Policy’ in Campaign Video
Many industry stakeholders and advocates pushed back, saying the White House hasn’t changed anything since Biden took office.
12 US Senators Say Cannabis Should Be Descheduled, Demand Transparency From DEA
The dozen Democrats requested responses to six questions regarding the DEA’s rescheduling process.
US Congressman Introduces Bill to Remove Cannabis From CSA, Allow Interstate Commerce, Provide 280E Relief
The legislation has bipartisan support, including from the co-chairs of the Congressional Cannabis Caucus.
6 Governors Push Biden to Reschedule Cannabis Before Year’s End
Head executives from Colorado, Illinois, Louisiana, Maryland, New Jersey and New York penned the letter to the White House.
UPDATE: US House Rep. Nancy Mace Files Federal Cannabis Legalization Bill
The South Carolina congresswoman has garnered bipartisan support for her legislation, but her own party could hold House Speaker turmoil against her.
Earl Blumenauer, Cannabis Reform Champion, Won’t Seek Reelection
The Oregon Democrat who founded the Congressional Cannabis Caucus has served his current U.S. House district since 1996.
Verano’s Potential Launching Pad
Aaron Miles, chief investment officer for Verano, discusses how a Cboe Canada listing could propel the company to U.S. exchanges.
Vote Count: How the SAFER Banking Act’s Markup Will Likely Shake Out
Two key Senate Banking Committee members will probably miss the markup hearing, but the revised legislation is poised for approval (maybe).
Opinion: Rescheduling Is Recriminalizing, Descheduling Is Decriminalizing
President of cannabis genetics company DNA Genetics, Rezwan Khan, weighs in on Biden's cannabis policy reform plan and how rescheduling or descheduling the plant would impact the industry.
Previous Page
Page 3 of 6
Next Page